Trial Profile
Pharmacokinetics and Safety Study of Rifamycin SV-MMX® 600 mg Tablets After Single and Multiple t.i.d. Doses in Healthy Male and Female Volunteers. Single and Multiple Dose, Open Label, Pharmacokinetics and Safety Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2018
Price :
$35
*
At a glance
- Drugs Rifamycin (Primary)
- Indications Diverticulitis; Traveller's diarrhoea
- Focus Pharmacokinetics
- Sponsors Cosmo Pharmaceuticals
- 23 Nov 2016 New trial record